Aktienanalyse zu Globe Life Inc (GL)GLGlobe Life Inc

Globe Life Inc. is an insurance holding company. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company's segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare. It operates in the Financials sector (LIFE INSURANCE industry).

Globe Life Inc is currently a hold. The current price is $164.17, which is below the average analyst price target of $201, indicating potential upside. However, the RSI is at 35.617, suggesting it is nearing oversold territory but not yet a strong buy signal. The recent insider selling has increased by 1066.49%, which raises concerns about insider confidence in the stock's near-term performance.